Hemoglobin is a heme-containing globular protein composed of four globin polypeptide chains, each bound to an iron‑containing heme group. In adults the common form is an α2β2 tetramer; the heme iron binds oxygen reversibly, enabling uptake in the lungs and release in peripheral tissues. This reversible oxygen binding is central to cellular respiration and metabolic function. Historically, hemoglobin measurement became a routine clinical assay because it reflects core aspects of blood health—oxygen delivery, red cell quantity, and hemoglobinization of cells. Its level and related red cell indices remain foundational in evaluating fatigue, exercise tolerance, recovery capacity, and broader circulatory status.

Elevated hemoglobin can reflect a relative increase in red cell concentration (for example due to reduced plasma volume or dehydration), physiological adaptation such as living at altitude, tobacco exposure, or processes that increase red cell production. High values should be interpreted alongside hydration status, red cell indices, and clinical history to distinguish transient shifts from sustained changes. Low hemoglobin indicates reduced oxygen-carrying capacity and may be associated with recent blood loss, low iron availability or other nutrient shortfalls (B12, folate), chronic inflammatory states, decreased red cell production, or fluid overload. Accurate interpretation requires correlation with iron studies, reticulocyte count, complete blood count indices, and the full Foundation Zoomer panel.

Hemoglobin is included in the Foundation Zoomer Blood Health domain to assess oxygen delivery, red cell mass, and interactions with iron and nutrient markers. Paired with iron studies, red cell indices, reticulocyte activity, and inflammatory markers, it helps reveal patterns underlying low stamina, fatigue, or altered recovery, supporting targeted follow-up and personalized care planning.